Pearce Wilcox

6.3k total citations
114 papers, 3.8k citations indexed

About

Pearce Wilcox is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Pearce Wilcox has authored 114 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Pulmonary and Respiratory Medicine, 20 papers in Physiology and 16 papers in Surgery. Recurrent topics in Pearce Wilcox's work include Cystic Fibrosis Research Advances (43 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (28 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers). Pearce Wilcox is often cited by papers focused on Cystic Fibrosis Research Advances (43 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (28 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers). Pearce Wilcox collaborates with scholars based in Canada, United States and Australia. Pearce Wilcox's co-authors include Richard L. Pardy, Christopher J. Ryerson, Bradley S. Quon, Despina D. Frangolias, Nancy Morrison, James V. Dunne, Mary Sue Fairbarn, Noel G. McElvaney, A. George F. Davidson and Peter D. Paré and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Pearce Wilcox

113 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pearce Wilcox Canada	38	2.7k	663	589	541	440	114	3.8k
Katherine L. Vandemheen Canada	33	2.3k 0.8×	1.3k 2.0×	843 1.4×	674 1.2×	153 0.3×	58	4.7k
Dennis J. Shale United Kingdom	39	3.0k 1.1×	963 1.5×	535 0.9×	493 0.9×	126 0.3×	99	4.3k
Mordechai R. Kramer Israel	35	2.2k 0.8×	478 0.7×	438 0.7×	874 1.6×	72 0.2×	182	3.7k
Attilio Boner Italy	41	2.6k 1.0×	3.1k 4.7×	653 1.1×	478 0.9×	434 1.0×	238	6.1k
Randeep Guleria India	27	1.4k 0.5×	730 1.1×	553 0.9×	324 0.6×	87 0.2×	207	3.2k
Christophe Delclaux France	36	3.2k 1.2×	1.4k 2.1×	1.1k 1.9×	546 1.0×	152 0.3×	191	5.7k
Dominique Robert France	33	2.0k 0.7×	776 1.2×	477 0.8×	614 1.1×	752 1.7×	111	4.4k
Christoph Fusch Germany	43	1.6k 0.6×	581 0.9×	1.1k 1.9×	698 1.3×	121 0.3×	192	5.5k
Marcello Ferrari Italy	27	1.0k 0.4×	1.1k 1.7×	231 0.4×	255 0.5×	365 0.8×	113	2.7k
Giovanni Rolla Italy	38	1.8k 0.7×	2.1k 3.2×	230 0.4×	728 1.3×	246 0.6×	183	4.2k

Countries citing papers authored by Pearce Wilcox

Since Specialization

Citations

This map shows the geographic impact of Pearce Wilcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pearce Wilcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pearce Wilcox more than expected).

Fields of papers citing papers by Pearce Wilcox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pearce Wilcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pearce Wilcox. The network helps show where Pearce Wilcox may publish in the future.

Co-authorship network of co-authors of Pearce Wilcox

This figure shows the co-authorship network connecting the top 25 collaborators of Pearce Wilcox. A scholar is included among the top collaborators of Pearce Wilcox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pearce Wilcox. Pearce Wilcox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Assayag, Deborah, Kerri A. Johannson, Charlene D. Fell, et al.. (2021). Treatment Initiation in Patients with Interstitial Lung Disease in Canada. Annals of the American Thoracic Society. 18(10). 1661–1668. 7 indexed citations

Shapera, Shane, Christopher J. Ryerson, Deborah Assayag, et al.. (2021). Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study. Respiratory Medicine. 191. 106722–106722. 6 indexed citations

Jung, David H., et al.. (2020). Circulating CRP and calprotectin to diagnose CF pulmonary exacerbations. Journal of Cystic Fibrosis. 20(1). 46–49. 9 indexed citations

Lam, Grace Y., et al.. (2020). Worsening pulmonary outcomes during sex reassignment therapy in a transgender female with cystic fibrosis (CF) and asthma/allergic bronchopulmonary aspergillosis: a case report. BMC Pulmonary Medicine. 20(1). 234–234. 8 indexed citations

Lam, Grace Y., et al.. (2020). Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes. ERJ Open Research. 7(1). 475–2020. 30 indexed citations

Sadatsafavi, Mohsen, Jolene H. Fisher, Julie Morisset, et al.. (2020). Costs of Workplace Productivity Loss in Patients with Connective Tissue Disease–associated Interstitial Lung Disease. Annals of the American Thoracic Society. 17(9). 1077–1084. 5 indexed citations

Wong, Alyson W., Deborah Assayag, Kerri A. Johannson, et al.. (2020). Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease. Thorax. 76(1). 37–43. 38 indexed citations

Fisher, Jolene H., Martin Kolb, Kerri A. Johannson, et al.. (2019). Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis. BMC Pulmonary Medicine. 19(1). 223–223. 53 indexed citations

Sadatsafavi, Mohsen, Jolene H. Fisher, Julie Morisset, et al.. (2019). Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease. CHEST Journal. 156(5). 887–895. 15 indexed citations

10.

Winstone, Tiffany A., Cameron Hague, Jeanette Soon, et al.. (2018). Oesophageal diameter is associated with severity but not progression of systemic sclerosis‐associated interstitial lung disease. Respirology. 23(10). 921–926. 15 indexed citations

11.

Wilcox, Pearce, Ian Glaspole, Tamera J. Corte, et al.. (2017). Cough is less common and less severe in systemic sclerosis‐associated interstitial lung disease compared to other fibrotic interstitial lung diseases. Respirology. 22(8). 1592–1597. 31 indexed citations

12.

Camp, Pat G., Kerri A. Johannson, Michele R. Schaeffer, et al.. (2017). Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD. Respirology. 23(4). 392–398. 57 indexed citations

13.

Ryerson, Christopher J., Charlene D. Fell, H. Manganas, et al.. (2016). The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry. Canadian Respiratory Journal. 2016. 1–7. 34 indexed citations

14.

Habib, Al‐Rahim, Jane A. Buxton, Joel Singer, et al.. (2015). Association between Chronic Rhinosinusitis and Health-Related Quality of Life in Adults with Cystic Fibrosis. Annals of the American Thoracic Society. 12(8). 1163–1169. 23 indexed citations

15.

Zlosnik, James E. A., Paulo Sucasas Costa, Rollin Brant, et al.. (2010). Mucoid and Nonmucoid Burkholderia cepacia Complex Bacteria in Cystic Fibrosis Infections. American Journal of Respiratory and Critical Care Medicine. 183(1). 67–72. 66 indexed citations

16.

Frangolias, Despina D., Caroline L. Holloway, Sverre Vedal, & Pearce Wilcox. (2003). Role of Exercise and Lung Function in Predicting Work Status in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 167(2). 150–157. 33 indexed citations

17.

Frangolias, Despina D., Eshwar Mahenthiralingam, Sandra Rae, et al.. (1999). Burkholderia cepacia in Cystic Fibrosis: Variable Disease Course. American Journal of Respiratory and Critical Care Medicine. 160(5). 1572–1577. 90 indexed citations

18.

Road, Jeremy, et al.. (1996). Effect of the Beta-Agonist Clenbuterol on Dexamethasone-Induced Diaphragm Dysfunction in Rabbits. American Journal of Respiratory and Critical Care Medicine. 154(6). 1778–1783. 15 indexed citations

19.

Wilcox, Pearce, Christine Milliken, & B Bressler. (1996). High-Dose Tumor Necrosis Factor Alpha Produces an Impairment of Hamster Diaphragm Contractility. Attenuation With a Prostaglandin Inhibitor. American Journal of Respiratory and Critical Care Medicine. 153(5). 1611–1615. 62 indexed citations

20.

Wilcox, Pearce, et al.. (1994). Tumor Necrosis Factor Alpha Decreases In Vivo Diaphragm Contractility in Dogs. American Journal of Respiratory and Critical Care Medicine. 150(5). 1368–1373. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact